会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明专利
    • DE69925266T2
    • 2005-10-06
    • DE69925266
    • 1999-03-03
    • MEDTRONIC INC
    • WARMAN NHILL RPETERSON KMEHRA RAHULMONGEON R
    • A61N1/362A61N1/39
    • An implantable anti-tachyarrhythmia device which delivers atrial cardioversion or defibrillation pulses heart in response to detection of atrial tachyarrhythmias. The pulses are synchronized to atrial and ventricular events in such a fashion as to assure they occur outside of the vulnerable periods associated with both chambers. The device is provided with a pulse synchronizer which defines a first synchronization interval initiated following a sensed atrial event and a second synchronization interval initiated responsive to a sensed ventricular event and a pulse triggerer which triggers delivery of a cardioversion or defibrillation pulse responsive to the first and second synchronization intervals simultaneously being underway. In particular, the pulse triggerer may be responsive to initiation of the first synchronization interval during the second synchronization interval. In addition, the synchronizer may also define minimum time intervals following ventricular events and the triggerer may additionally be responsive to expiration of a defined minimum time interval following a ventricular event preceding the sensed ventricular event which initiated the second synchronization interval currently underway.
    • 5. 发明专利
    • DE69824170T2
    • 2005-06-23
    • DE69824170
    • 1998-02-09
    • MEDTRONIC INC
    • HILL R
    • A61N1/05A61N1/362A61N1/39
    • A cardiac pacemaker with a rate stabilization pacing mode. The pacemaker varies the increment following a cycle ending in a sensed depolarization as a function of the underlying heart rate and may additionally vary the increment as a function of the prematurity of the most recently sensed depolarization relative to the preceding depolarization. A greater increment is generally provided if the underlying cycle length is greater, while the increment may be lessened following relatively more premature depolarizations. Prematurity may be determined by comparing the cycle (CLnew) ending in the most recently sensed depolarization with the previous cycle length (CLold), for example by calculating CLnew/CLold or CLold-CLnew. The mechanism for determining the duration of the increment provides for a more rapid return to a lower underlying heart rate, while still avoiding the short-long interval pattern sometimes associated with the onset of tachycardia.
    • 7. 发明专利
    • DE69824170D1
    • 2004-07-01
    • DE69824170
    • 1998-02-09
    • MEDTRONIC INC
    • HILL R
    • A61N1/05A61N1/362A61N1/39
    • A cardiac pacemaker with a rate stabilization pacing mode. The pacemaker varies the increment following a cycle ending in a sensed depolarization as a function of the underlying heart rate and may additionally vary the increment as a function of the prematurity of the most recently sensed depolarization relative to the preceding depolarization. A greater increment is generally provided if the underlying cycle length is greater, while the increment may be lessened following relatively more premature depolarizations. Prematurity may be determined by comparing the cycle (CLnew) ending in the most recently sensed depolarization with the previous cycle length (CLold), for example by calculating CLnew/CLold or CLold-CLnew. The mechanism for determining the duration of the increment provides for a more rapid return to a lower underlying heart rate, while still avoiding the short-long interval pattern sometimes associated with the onset of tachycardia.
    • 8. 发明专利
    • DE69925266D1
    • 2005-06-16
    • DE69925266
    • 1999-03-03
    • MEDTRONIC INC
    • WARMAN NHILL RPETERSON KMEHRA RAHULMONGEON R
    • A61N1/362A61N1/39
    • An implantable anti-tachyarrhythmia device which delivers atrial cardioversion or defibrillation pulses heart in response to detection of atrial tachyarrhythmias. The pulses are synchronized to atrial and ventricular events in such a fashion as to assure they occur outside of the vulnerable periods associated with both chambers. The device is provided with a pulse synchronizer which defines a first synchronization interval initiated following a sensed atrial event and a second synchronization interval initiated responsive to a sensed ventricular event and a pulse triggerer which triggers delivery of a cardioversion or defibrillation pulse responsive to the first and second synchronization intervals simultaneously being underway. In particular, the pulse triggerer may be responsive to initiation of the first synchronization interval during the second synchronization interval. In addition, the synchronizer may also define minimum time intervals following ventricular events and the triggerer may additionally be responsive to expiration of a defined minimum time interval following a ventricular event preceding the sensed ventricular event which initiated the second synchronization interval currently underway.
    • 10. 发明专利
    • DE60030555D1
    • 2006-10-19
    • DE60030555
    • 2000-02-02
    • MEDTRONIC INC
    • HILL RMEHRA RAHULHESS FPITSCHNEIDER RAYLENE
    • A61N1/37A61N1/08
    • A method and apparatus for determining the occurrence of a mis-location of an atrial electrode in a cardiac stimulation device having an atrial pulse generator coupled with the atrial electrode and a ventricular sense amplifier coupled to a ventricular electrode. The device paces the atrium in a first pacing mode employing atrial pacing pulses at a first energy level and in a test mode employs higher energy atrial pacing pulses. In the test mode the device measures PR intervals between atrial pacing pulses following sensed ventricular depolarizations and determines that the atrial electrode is mis-located responsive to occurrence of a threshold number of short PR intervals or that the atrial electrode is appropriately located responsive to occurrence of a threshold number of long PR intervals. Operation of the device in the test mode may be pre-conditioned on an absence of atrial tachyarrhythmia.